Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

Systematic review: Efficacy and safety of medical marijuana in selected neurologic disorders: Report of the Guideline Development Subcommittee of the American Academy of Neurology.
Preventive effect of vitamin D3 supplementation on conversion of optic neuritis to clinically definite multiple sclerosis: a double blind, randomized, placebo-controlled pilot clinical trial.
Embryonic stem cell lines derived from human blastocysts.
UPDATE 2-FDA panel supports approval of Sanofi's MS drug Lemtrada
A controlled trial of natalizumab for relapsing multiple sclerosis.
Sensitivity and specificity of SWI venography for detection of cerebral venous alterations in multiple sclerosis.
Novartis receives European Commission approval for Gilenya®, the first oral multiple sclerosis treatment for use in the EU
Daclizumab reverses intrathecal immune cell abnormalities in multiple sclerosis.
Delta-9-THC in the treatment of spasticity associated with multiple sclerosis.
Effect of natalizumab treatment on circulating plasmacytoid dendritic cells: a cross-sectional observational study in patients with multiple sclerosis.
Vitamin D3 Receptor ( VDR ) Gene rs2228570 (Fok1) and rs731236 (Taq1) Variants Are Not Associated with the Risk for Multiple Sclerosis: Results of a New Study and a Meta-Analysis.
Secukinumab in the treatment of noninfectious uveitis: results of three randomized, controlled clinical trials.
Long term follow up of peripheral lymphocyte subsets in a cohort of multiple sclerosis patients treated with natalizumab.
Activities of daily living: evaluation and treatment in persons with multiple sclerosis.
Design and screening of a glial cell-specific, cell penetrating Peptide for therapeutic applications in multiple sclerosis.
Paediatric acquired demyelinating syndromes: incidence, clinical and magnetic resonance imaging features.
Current Immune Therapies of Autoimmune Disease of the Nervous System with Special Emphasis to Multiple Sclerosis.
Acute disseminated encephalomyelitis--a prospective study of clinical profile and in-hospital outcome predictors.
Comparative injection-site pain and tolerability of subcutaneous serum-free formulation of interferonβ-1a versus subcutaneous interferonβ-1b: results of the randomized, multicenter, Phase IIIb REFORMS study.
Effects of natalizumab on oligoclonal bands in the cerebrospinal fluid of multiple sclerosis patients: A longitudinal study.
No impact of current therapeutic strategies on disease reactivation after natalizumab discontinuation: a comparative analysis of different approaches during the first year of natalizumab discontinuation.
Expression of IL-33 and its epigenetic regulation in Multiple Sclerosis.
Phenytoin for neuroprotection in patients with acute optic neuritis: a randomised, placebo-controlled, phase 2 trial.
Visual dysfunction in multiple sclerosis correlates better with optical coherence tomography derived estimates of macular ganglion cell layer thickness than peripapillary retinal nerve fiber layer thickness.
Magnetic Resonance Imaging of Optic Neuritis in Patients With Neuromyelitis Optica Versus Multiple Sclerosis.

Pages